ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
S

Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early Breast Cancer: Factors Increasing the Rate of Treatment Discontinuations in monarchE

By ASCO 2022 Conference Coverage FEATURING Sara Tolaney
By ASCO 2022 Conference Coverage FEATURING Sara Tolaney
0 views
July 26, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
Breast
54
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early…

Feat. S. Tolaney
07:17
ASCO 2022 Conference Coverage

ASCO 2022 Adjuvant Abemaciclib for High-Risk Early Breast Cancer: Fa…

Feat. S. Tolaney
01:10
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 A Phase 1b/2 Study of the BET Inhibitor …

Feat. P. Aftimos
10:53
ASCO 2022 Conference Coverage

ASCO 2022 A Phase 1b/2 Study of the BET Inhibitor ZEN-3694 in Combin…

Feat. P. Aftimos
10:23
ASCO 2022 Conference Coverage

ASCO 2022 Phase 2 Study of Lasofoxifene + Abemaciclib for Treating P…

Feat. S. Damodaran
10:12
ASCO 2022 Conference Coverage

ASCO 2022 on FLEX - the 30,000 Breast Cancer Transcriptome Project: …

Feat. C. Ma
01:04
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Phase 2 Study of Lasofoxifene + Abemacic…

Feat. S. Damodaran
52
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on FLEX - the 30,000 Breast Cancer Trans…

Feat. C. Ma
01:17
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Monitoring and Management of Intersti…

Feat. B. Feinberg
11:56
ASCO 2022 Conference Coverage

ASCO 2022 on Monitoring and Management of Interstitial Lung Disease/…

Feat. B. Feinberg
04:01
ASCO 2022 Conference Coverage

ASCO 2022 on Sacituzumab Govitecan vs. Treatment of Physician’s Choi…

Feat. A. Bardia
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Sacituzumab Govitecan vs. Treatment o…

Feat. A. Bardia
09:57
ASCO 2022 Conference Coverage

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

Feat. C. Dang
01:06
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

Feat. C. Dang
06:19
ASCO 2022 Conference Coverage

ASCO 2022 Phase 2 Study of Response-Guided Neoadjuvant Sacituzumab G…

Feat. L. Spring
48
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Phase 2 Study of Response-Guided Neoadju…

Feat. L. Spring
04:16
ASCO 2022 Conference Coverage

ASCO 2022 Analyses From PALOMA-2: Overall Survival With 1L Palbocicl…

Feat. D. Slamon
03:10
ASCO 2022 Conference Coverage

ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Immunotherapy With P…

Feat. H. McArthur
04:36
ASCO 2022 Conference Coverage

ASCO 2022 A Single-Arm, Phase 2 Study of Perioperative Ipi, Nivo, an…

Feat. H. McArthur
56
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Neoadjuvant HER2-Targeted Therapy +/- Im…

Feat. H. McArthur
37
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 A Single-Arm, Phase 2 Study of Periopera…

Feat. H. McArthur
50
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on a Randomized Phase II/III PARTNER Tri…

Feat. R. Lucey
05:52
ASCO 2022 Conference Coverage

ASCO 2022 on a Randomized Phase II/III PARTNER Trial to Evaluate the…

Feat. R. Lucey
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Overall Survival With 1L Palbociclib + L…

Feat. D. Slamon
03:41
ASCO 2022 Conference Coverage

ASCO 2022 Adherence to EndoPredict Test Scores for Extended ET Manag…

Feat. A. Brufsky
47
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adherence to EndoPredict Test Scores for…

Feat. A. Brufsky
01:03
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on EFS by Residual Cancer Burden After N…

Feat. L. Pusztai
13:17
ASCO 2022 Conference Coverage

ASCO 2022 on EFS by Residual Cancer Burden After Neoadjuvant Pembro …

Feat. L. Pusztai
05:13
ASCO 2022 Conference Coverage

ASCO 2022 Optimization of the Duration of Adjuvant Endocrine Therapy…

Feat. B. Pistilli
34
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Trastuzumab Deruxtecan vs. Trastuzumab E…

Feat. E. Hamilton
28
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Optimization of the Duration of Adjuvant…

Feat. B. Pistilli
44
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Impact of BMI on Treatment and Outcomes …

Feat. G. Pfeiler
43
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Alpelisib + Continued ET Following Pr…

Feat. C. Truica
04:56
ASCO 2022 Conference Coverage

ASCO 2022 Impact of BMI on Treatment and Outcomes in Patients With H…

Feat. G. Pfeiler
06:50
ASCO 2022 Conference Coverage

ASCO 2022 on Alpelisib + Continued ET Following Progression on ET in…

Feat. C. Truica
04:28
ASCO 2022 Conference Coverage

ASCO 2022 Subgroup Analysis of Patients With No Prior Chemo in Phase…

Feat. V. Kaklamani
30
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Subgroup Analysis of Patients With No Pr…

Feat. V. Kaklamani
01:18
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Survival Outcomes in Metastatic HR+, HER…

Feat. J. Mouabbi
09:18
ASCO 2022 Conference Coverage

ASCO 2022 Survival Outcomes in Metastatic HR+, HER2- IDC Compared to…

Feat. J. Mouabbi
31
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on NRG-BR007: A Phase III Trial Evaluati…

Feat. J. White
10:55
ASCO 2022 Conference Coverage

ASCO 2022 on NRG-BR007: A Phase III Trial Evaluating De-Escalation o…

Feat. J. White
01:21
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Type of ET and DFS in Early HER2+…

Feat. M. Vittoria Dieci
06:57
ASCO 2022 Conference Coverage

ASCO 2022 on the Type of ET and DFS in Early HER2+/HR+ BC: Analysis …

Feat. M. Vittoria Dieci
49
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022: The ImPrint Immune Signature to Identif…

Feat. L. Mittempergher
11:09
ASCO 2022 Conference Coverage

ASCO 2022: The ImPrint Immune Signature to Identify Patients With Hi…

Feat. L. Mittempergher
32
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Estradiol Levels in Premenopausal Wom…

Feat. M. Tesch
10:19
ASCO 2022 Conference Coverage

ASCO 2022 on Estradiol Levels in Premenopausal Women With HR+ BC on …

Feat. M. Tesch
01:37
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

Feat. S. Shen
06:32
ASCO 2022 Conference Coverage

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

Feat. S. Shen
27
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on Disparity Between Ki67 Measurements a…

Feat. R. Stein
08:04
ASCO 2022 Conference Coverage

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

Feat. R. Stein